{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:22:38Z","timestamp":1791105758341,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1124\/jpet.109.162396","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T02:01:02Z","timestamp":1267668062000},"page":"929-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Nicotinic Receptor-Mediated Reduction in l-DOPA-Induced Dyskinesias May Occur via Desensitization"],"prefix":"10.1016","volume":"333","author":[{"given":"Tanuja","family":"Bordia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryka","family":"Quik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.162396_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.109.162396_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","article-title":"Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease","volume":"8","author":"Benabid","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.109.162396_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1124\/jpet.108.140897","article-title":"Continuous and intermittent nicotine treatment reduces l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson's disease","volume":"327","author":"Bordia","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.108.145292","article-title":"Desensitization of nicotinic acetylcholine receptors as a strategy for drug development","volume":"328","author":"Buccafusco","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0197-4580(91)90102-P","article-title":"Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys","volume":"12","author":"Buccafusco","year":"1991","journal-title":"Neurobiol Aging"},{"key":"10.1124\/jpet.109.162396_bib6","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/S0024-3205(03)00226-1","article-title":"The potential role of cotinine in the cognitive and neuroprotective actions of nicotine","volume":"72","author":"Buccafusco","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/jpet.109.162396_bib7","unstructured":"Campos C, Perez X, Jordan K, Letchworth S, Quik M (2009) Nicotinic receptor subtype agonists reduce l-DOPA-induced dyskinetic movements in parkinsonian rats, in Abstracts from Neuroscience 2009; 2009 Oct 17\u201321; Chicago. Society for Neuroscience, Washington, DC."},{"key":"10.1124\/jpet.109.162396_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0079-6123(08)00922-9","article-title":"Serotonin\u2013dopamine interaction in the induction and maintenance of l-DOPA-induced dyskinesias","volume":"172","author":"Carta","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.109.162396_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0925s41","article-title":"Ratings of l-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","author":"Cenci","year":"2007","journal-title":"Curr Protoc Neurosci"},{"key":"10.1124\/jpet.109.162396_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jphysparis.2005.12.012","article-title":"Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural plasticity?","volume":"99","author":"Corringer","year":"2006","journal-title":"J Physiol Paris"},{"key":"10.1124\/jpet.109.162396_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/ALN.0b013e3181834490","article-title":"Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug","volume":"109","author":"Cucchiaro","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.109.162396_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.109.162396_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2008.09.009","article-title":"In vivo activation of midbrain dopamine neurons via sensitized, high-affinity \u03b16 nicotinic acetylcholine receptors","volume":"60","author":"Drenan","year":"2008","journal-title":"Neuron"},{"key":"10.1124\/jpet.109.162396_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0022-3565(24)38040-1","article-title":"(S)-(\u2212)-cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner","volume":"288","author":"Dwoskin","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib15","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/sj.npp.1301617","article-title":"\u03b16-Containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens","volume":"33","author":"Exley","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.109.162396_bib16","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/ana.21453","article-title":"How do you treat motor complications in Parkinson's disease: medicine, surgery, or both?","volume":"64","author":"Fahn","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.109.162396_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6123(08)00923-0","article-title":"Parkinson's disease: opportunities for novel therapeutics to reduce the problems of levodopa therapy","volume":"172","author":"Fox","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.109.162396_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3458.2004.tb00010.x","article-title":"TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective, and long-lasting cognitive effects","volume":"10","author":"Gatto","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1124\/jpet.109.162396_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.109.162396_bib20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bcp.2007.07.032","article-title":"The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum","volume":"74","author":"Grady","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.109.162396_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12031-009-9263-y","article-title":"Mouse striatal dopamine nerve terminals express \u03b14\u03b15\u03b22 and two stoichiometric forms of \u03b14\u03b2*-nicotinic acetylcholine receptors","volume":"40","author":"Grady","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.109.162396_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12640-009-9041-1","article-title":"Nicotine induces sensitization of turning behavior in 6-hydroxydopamine-lesioned rats","volume":"15","author":"Greg\u00f3rio","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.109.162396_bib23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/jpet.104.071142","article-title":"Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on l-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys","volume":"311","author":"Hsu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib24","unstructured":"Huang LZ, Bordia T, Quik M (2009) Nicotine treatment reduces l-DOPA-induced dyskinetic-like movements in parkinsonian mice in Abstracts from Neuroscience 2009; 2009 Oct 17\u201321; Chicago. Society for Neuroscience, Washington, DC."},{"key":"10.1124\/jpet.109.162396_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3565(25)13322-3","article-title":"Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine","volume":"252","author":"Hulihan-Giblin","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-3565(25)13332-6","article-title":"Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine","volume":"252","author":"Hulihan-Giblin","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib27","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1124\/mol.105.012419","article-title":"Nicotine acts as a pharmacological chaperone to up-regulate human \u03b14\u03b22 acetylcholine receptors","volume":"68","author":"Kuryatov","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.109.162396_bib28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/jpet.105.085381","article-title":"Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure","volume":"314","author":"Lockman","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00213-006-0441-0","article-title":"Guidelines on nicotine dose selection for in vivo research","volume":"190","author":"Matta","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.109.162396_bib30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1471-4159.2008.05266.x","article-title":"The neuronal nicotinic acetylcholine receptors \u03b14* and \u03b16* differentially modulate dopamine release in mouse striatal slices","volume":"105","author":"Meyer","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.109.162396_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.108.136838","article-title":"Cotinine selectively activates a subpopulation of \u03b13\/\u03b16\u03b22* nicotinic receptors in monkey striatum","volume":"325","author":"O'Leary","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.162396_bib32","unstructured":"Parameswaran N, Huang LZ, Lee Y, Carroll FI, Quik M (2009) Effect of nAChR agonists on l-DOPA-induced dyskinesias in parkinsonian rats in Abstracts from Neuroscience 2009; 2009 Oct 17\u201321; Chicago. Society for Neuroscience, Washington, DC."},{"key":"10.1124\/jpet.109.162396_bib33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/mol.108.048843","article-title":"Long-term nicotine treatment differentially regulates striatal \u03b16\u03b14\u03b22* and \u03b16(non\u03b14)\u03b22* nAChR expression and function","volume":"74","author":"Perez","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.109.162396_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1124\/jpet.109.162396_bib35","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1523\/JNEUROSCI.3918-08.2008","article-title":"Crucial role of \u03b14 and \u03b16 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration","volume":"28","author":"Pons","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.109.162396_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.21203","article-title":"Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys","volume":"62","author":"Quik","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.109.162396_bib37","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.21900","article-title":"Nicotine and Parkinson's disease: implications for therapy","volume":"23","author":"Quik","year":"2008","journal-title":"Mov Disord"},{"key":"10.1124\/jpet.109.162396_bib38","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.109.162396_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism, and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.109.162396_bib40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1468-1331.2009.02697.x","article-title":"Levodopa in the treatment of Parkinson's disease","volume":"16","author":"Schapira","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1124\/jpet.109.162396_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0006-3223(97)00477-0","article-title":"Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats","volume":"43","author":"Semba","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.109.162396_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.109.162396_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1098-2299(199907)47:3<127::AID-DDR3>3.0.CO;2-#","article-title":"Dose-specific improvements in memory-related task performance by rats and aged monkeys administered the nicoitnic-cholinerigc antagonist mecamylamine","volume":"47","author":"Terry","year":"1999","journal-title":"Drug Dev Res"},{"key":"10.1124\/jpet.109.162396_bib44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s002130050758","article-title":"Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: psychiatric implications","volume":"140","author":"Tizabi","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.109.162396_bib45","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1523\/JNEUROSCI.5240-04.2005","article-title":"Chronic nicotine exposure up-regulates nicotinic receptors by a novel mechanism","volume":"25","author":"Vallejo","year":"2005","journal-title":"J Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524458163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524458163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.162396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:11:58Z","timestamp":1740017518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524458163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0022356524458163"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.162396","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinic Receptor-Mediated Reduction in l-DOPA-Induced Dyskinesias May Occur via Desensitization","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.162396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}